Skip to search formSkip to main contentSkip to account menu

soretolide

Known as: 2,6-dimethylbenzamide-N-(5-methyl-3-isoxazole) 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2001
2001
Laboratoires Biocodex is developing soretolide (D-2916) as a potential treatment for epilepsy. It is currently in phase II trials…